Vadastuximab Antibody
Vadastuximab is a humanized monoclonal antibody targeting CD33, primarily utilized in acute myeloid leukemia (AML) research. It serves as the key component for constructing the antibody-drug conjugate vadastuximab talirine and is employed in both in vitro and in vivo studies to investigate targeted therapies against AML.
Product Specifications
Product Name Alternative
Immunology related, Immunologyrelated, Inflammation related, Inflammationrelated, Anti-Human CD33 Recombinant Antibody, CD33
Target
Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.32 mg/mL
Purity
97.30% (May vary between batches)
Molecular Weight
144.81 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
